Fund moves

Roivant Sciences (ROIV): Rubric Capital Management LP reduced its stake -11M shares

Rubric Capital Management LP reduced its stake in Roivant Sciences, per its Q4 2025 13F.

9M
Shares reported · -11M vs prior quarter
2.3%
Disclosed portfolio weight
$195M
Reported value
Holdings as of
Dec 31, 2025
Filed
Feb 13, 2026

What stands out in this filing

  • 20,000,000 shares in Q3 2025, 9,000,000 now (−55.0% in share count).
  • Reported at $195M, 2.34% of the portfolio value in this 13F filing.
  • 9 other tracked managers reported the same kind of change for Q4 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 11, 2025Insider10% owner sold ~$16.8M of ROIV shares in the open market
  2. Dec 12, 2025Insider · Their largest sale since 202310% owner sold ~$43.4M of ROIV shares in the open market
  3. Dec 15, 2025Insider · 2 peopleInsiders: 4 sales (~$45.5M)
  4. Dec 16, 2025Insider · 3 peopleInsiders: 6 sales (~$63.4M)
  5. Dec 17, 2025Insider · 4 peopleInsiders: 10 sales (~$54.4M)
  6. Dec 23, 2025Insider · 2 peopleInsiders: 3 sales (~$13.6M)
  7. Dec 24, 2025InsiderCEO sold ~$1.69M of ROIV shares in the open market
  8. Dec 29, 2025InsiderDirector sold ~$6.78M of ROIV shares in the open market
  9. Dec 31, 2025Insider · Their largest sale since 2024Director sold ~$22.1M of ROIV shares in the open market
  10. Jan 12, 2026InsiderCEO sold ~$4.38M of ROIV shares in the open market
  11. Feb 6, 2026Company filing · Form 8-K · ResultsReported its results
  12. Feb 9, 2026InsiderDirector sold ~$8.99M of ROIV shares in the open market
  13. Feb 11, 2026Insider · 3 peopleInsiders: 3 sales (~$34.0M)
  14. Feb 12, 2026Insider · 3 peopleInsiders: 6 sales (~$34.1M)
  15. Feb 13, 2026Insider · 4 peopleInsiders: 7 sales (~$35.2M)

What came next

  1. Feb 19, 2026InsiderChair sold ~$38.4M of ROIV shares in the open market
  2. Feb 20, 2026InsiderChair sold ~$27.5M of ROIV shares in the open market
  3. Feb 23, 2026InsiderChair sold ~$16.2M of ROIV shares in the open market
  4. Mar 3, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  5. Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  6. Mar 16, 2026InsiderDirector sold ~$1.2M of ROIV shares in the open market
  7. Mar 17, 2026InsiderCEO sold ~$5.65M of ROIV shares in the open market
  8. Mar 26, 2026Insider · 7 days before resultsDirector sold ~$1.92M of ROIV shares in the open market
  9. Apr 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  10. Apr 8, 2026InsiderOfficer sold ~$384K of ROIV shares in the open market
  11. Apr 16, 2026InsiderCEO sold ~$8.45M of ROIV shares in the open market
  12. Apr 20, 2026InsiderCEO sold ~$5.92M of ROIV shares in the open market
  13. May 20, 2026Company filing · Form 8-K · ResultsReported its results
  14. May 22, 2026InsiderCEO sold ~$6.05M of ROIV shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 55 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

How this filing works

Explore the data

Common questions

What does this filing report about Roivant Sciences (ROIV) stock?

Rubric Capital Management LP reduced its stake in Roivant Sciences, per its Q4 2025 13F. Now 9M shares, $195M reported value, 2.3% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: Feb 13, 2026.

What stands out in this filing?

20,000,000 shares in Q3 2025, 9,000,000 now (−55.0% in share count). Reported at $195M, 2.34% of the portfolio value in this 13F filing. 9 other tracked managers reported the same kind of change for Q4 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Roivant Sciences recently?

For Roivant Sciences, OQRO holds 55 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ROIV page.

Does this mean ROIV stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data